NCCN 2026 Breast Cancer Congress Updates

from Medical News Podcast · host PeerDirect Publishing

Drs. Waks and Sammons discuss how new long-term data and key updates in the NCCN Guidelines® are reshaping treatment strategies for HER2+ breast cancer in both early-stage and metastatic settings. They highlight the growing role of T-DXd, including its benefits, risks, and optimal patient selection, alongside how to sequence it with other HER2-directed therapies like pertuzumab and T-DM1.

Episode metadata supplied by the publisher feed · Published Jun 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

NCCN 2026 Breast Cancer Congress Updates

0:00 10:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 10 minutes long.

When was this Medical News Podcast episode published?

This episode was published on June 23, 2026.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!